𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies

✍ Scribed by P. Ragnhammar; J. -E. Frödin; P. P. Trotta; H. Mellstedt

Publisher
Springer-Verlag
Year
1994
Tongue
English
Weight
935 KB
Volume
39
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intraclonal diversity of fibrosarcoma ce
Intraclonal diversity of fibrosarcoma cells for the production of macrophage colony-stimulating factor and granulocyte colony-stimulating factor
✍ Nobuo Sakai; Masao Kubota; Mikio Shikita; Masahiko Yokota; Koichi Ando 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

shi, Tokyo 794 (N.S.), and Division of Pharmaceutical Science (M. K., M.S.) and Clinical Research (M. Y., K.A.), National Institute of Radiological Sciences, Chiba-shi 260, Japan A new cell line was established from fibrosarcoma that had spontaneously developed in a mouse. The cells were maintained

Effect of serum deprivation on constitut
Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells
✍ Yoshiki Uemura; Makoto Kobayashi; Hideshi Nakata; Ryoji Harada; Tetsuya Kubota; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 394 KB 👁 1 views

## Abstract We previously established 2 lung cancer cell lines, OKa‐C‐1 and MI‐4, which constitutively produce an abundant dose of granulocyte‐colony stimulating factor (G‐CSF) and granulocyte macrophage‐colony stimulating factor (GM‐CSF). Many other cases with G‐CSF or GM‐CSF producing tumors have

Recombinant human granulocyte-colony sti
Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice
✍ Hal E. Broxmeyer; Douglas E. Williams; Scott Cooper; Giao Hangoc; Peter Ralph 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Combinations of low dosages of purified recombinant human (rh) macrophagecolony stimulating factor (M-CSF; also termed CSF-1) and rh granulocyte-colony stimulating factor (G-CSF) were compared alone and in combination for their influence on the cycling rates and numbers of bone marrow and splenic gr

Treatment of de novo acute myelogenous l
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: Effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts
✍ Valent, Peter ;Sillaber, Christian ;Geissler, Klaus ;Andreeff, Michael ;Tafuri, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of